Dublin, Dec. 16, 2021 (GLOBE NEWSWIRE) -- The "Global Fertility Testing Market (2021-2026) by Application, Mode of Purchase, Product, End-User & Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.
The Global Fertility Testing Market is estimated to be USD 280.25 Mn in 2021 and is expected to reach USD 416.37 Mn by 2026, growing at a CAGR of 8.24%.
Market Dynamics
Both men and women undertake fertility testing to assess their fertility and various conditions associated with it. Both men and women experience fertility problems at equal rates, but women are considered more concerned about fertility testing.
The key factors impacting the Global Fertility Testing Market are declining fertility rates across the globe, increasing awareness about fertility testing, the introduction of advanced and easy-to-use fertility monitors with high accuracy, increasing first-time pregnancy age in women.
However, the high price associated with ovulation monitors and lesser precision to confirm ovulation is some of the factors that may hinder the market growth.
Market Segmentation
- By Application, the market is classified into Male and Female Fertility Testing.
- By Mode of Purchase, the market is classified into Prescription Based Products, OTC-Based Products, and Online Products.
- By Product, the market is classified into Ovulation Prediction Kits, Fertility Monitoring Devices, and Male Fertility Testing Products.
- By End User, the market is classified into Home Care settings, Hospitals, and Specialty Clinics & Fertility Center.
- By Geography, North America is expected to lead the market.
Recent Developments
Fertility Focus announces the launch of OvuFirst Skin-Worn Sensor to add support for women starting on their journey to pregnancy. - 7th June 2021
Legacy, the premier digital fertility clinic for men, announced USD 10M in Series A fundraising led by FirstMark Capital. - 14th April 2021
Ava Announces launch of First Clinical Trial evaluating the effectiveness of its Fertility Tracking Sensor Bracelet in Real-time, pre-symptomatic Detection of COVID-19. - 23rd March 2021
Market Influencers
Drivers
- Declining Fertility Rate Among Men and Women
- Increasing Awareness About Fertility Testing
- Increasing First-Time Pregnancy Age in Women
Restraints
- High Price Associated with Fertility Testing Monitors
- Lesser Precision of Ovulation Prediction Kits
Opportunities
- Combined Testing Kit for Pregnancy and Ovulation
- Emerging Nations to Offer New Growth Avenues
Challenges
- Malfunctioning of Urine-Based Ovulation Monitors
Some of the companies covered in this report are
- Swiss Precision Diagnostics
- Church & Dwight
- Prestige Consumer Healthcare
- BioZhena
- Fairhaven Health
- Fertility Focus
- Geratherm Medical
- Hilin Life Products
- UEBE Medical
- AdvaCare Pharma
- AVA
- Quidel Corporation
- Valley Electronics
- Sensiia
- Mira Care
- AccuQuik
- Alere Inc.
- BabyStart
- SPD Swiss Precision Diagnostics GmbH
- Taidoc Technology Corporation
For more information about this report visit https://www.researchandmarkets.com/r/sy76ad
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
